| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 6, 2025Virtual Press Office and PR Newswire: General Trade show news
Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following...
-
Nov 6, 2025Virtual Press Office and PR Newswire: General Trade show news
Studies highlight findings in the use of (Z)-endoxifen to advance breast cancer treatment and prevention SEATTLE, Nov. 6, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or...
-
Nov 6, 2025CES Exhibitor News releases, photos and supporting content
Joint solution accelerating AI-powered AV development, validation, and testing TEL AVIV, Israel and SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ -- Foretellix, the leading Physical AI toolchain...
-
Nov 6, 2025Virtual Press Office and PR Newswire: General Trade show news
Program brings together healthcare entrepreneurs to advance innovations in digital health, medtech, and care delivery across the Middle East and globally NEW YORK, Nov. 6, 2025 /PRNewswire/ --...
-
Nov 6, 2025Virtual Press Office and PR Newswire: General Trade show news
Oral MC4R agonist PL7737 demonstrated robust weight loss, safety, and high oral bioavailability in preclinical models Clinical data supports co-administration of an MC4R agonist with tirzepatide...
